TNFSF10 and respiratory tract infectious disorder: Whereas first identified as factor produced by immune cells in non-respiratory infection (8, 9), TRAIL is now especially well studied in influenza A virus (IAV) infection, where it is released in high amounts from bone marrow-derived macrophages upon pathogen-associated molecular patterns (PAMPs) recognition and type I IFN production (10).